CiloaS
Dedicated to the production of fully native membrane proteins on exosomes.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD30—45m (Dealroom.co estimates Mar 2022.)
Company register number 531963692
Montpellier Occitanie (HQ)
Financials
Estimates*
EUR | 2016 |
---|---|
Revenues | <1m |
EBITDA | (<1m) |
% EBITDA margin | (4 %) |
Profit | (<1m) |
% profit margin | (54 %) |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Spinout | ||
N/A | Grant | ||
* | N/A | €5.0m | Early VC |
Total Funding | CAD7.5m |
Related Content
Recent News about CiloaS
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.